Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Am J Surg Pathol. 2011 Dec;35(12):1766-75. doi: 10.1097/PAS.0b013e31822f58bc.
There is compelling evidence that serous tubal intraepithelial carcinoma (STIC) is a precursor of high-grade serous ovarian carcinoma. Large-scale studies are now required to determine its biological significance and clinical implication. Before conducting these studies, a reproducible classification for STIC is needed, and that is the goal of this study. This study involved 6 gynecologic pathologists from 4 academic institutions and 3 independent rounds of review. In round 1, sixty-seven lesions ranging from normal, atypical, to STICs were classified by 5 pathologists on the basis of predetermined morphologic criteria. Interobserver agreement for the diagnosis of STIC versus not STIC was fair [κ = 0.39; 95% confidence interval (CI) 0.26, 0.52], and intraobserver reproducibility ranged from fair to moderate on the basis of percentage agreement and κ. Round 2 involved testing revised criteria that incorporated morphology and immunohistochemistry (IHC) for p53 protein expression and Ki-67 labeling in 10 sets by 3 of the pathologists. The result was an improvement in interobserver agreement for the classification of STIC (κ = 0.62; 95% CI 0.18, 1.00). An algorithm was then created combining morphology and IHC for p53 and Ki-67, and reproducibility was assessed as part of round 3. In 37 lesions reviewed by 6 pathologists, substantial agreement for STIC versus no STIC was observed (κ = 0.73; 95% CI 0.58, 0.86). In conclusion, we have developed reproducible criteria for the diagnosis of STIC that incorporate morphologic and IHC markers for p53 and Ki-67. The algorithm we propose is expected to help standardize the classification of STIC for future studies.
有确凿的证据表明输卵管上皮内癌(STIC)是高级别浆液性卵巢癌的前身。现在需要进行大规模的研究来确定其生物学意义和临床意义。在进行这些研究之前,需要一种可重复的 STIC 分类方法,这就是本研究的目的。本研究涉及来自 4 所学术机构的 6 名妇科病理学家和 3 轮独立的审查。在第 1 轮中,5 名病理学家根据预定的形态学标准对 67 个病变进行分类,范围从正常、非典型到 STIC。STIC 与非 STIC 的诊断观察者间一致性为中等(κ=0.39;95%置信区间[CI]0.26,0.52),基于百分比一致性和κ的观察者内可重复性范围从中等到适度。第 2 轮涉及测试修订后的标准,这些标准纳入了形态学和免疫组织化学(IHC),用于 3 名病理学家的 10 个标本中 p53 蛋白表达和 Ki-67 标记。结果是 STIC 分类的观察者间一致性得到改善(κ=0.62;95%CI0.18,1.00)。然后创建了一个结合形态学和 p53 和 Ki-67 的 IHC 的算法,并在第 3 轮评估了可重复性。在由 6 名病理学家审查的 37 个病变中,观察到 STIC 与非 STIC 的显著一致性(κ=0.73;95%CI0.58,0.86)。总之,我们已经制定了用于诊断 STIC 的可重复标准,该标准纳入了 p53 和 Ki-67 的形态学和 IHC 标志物。我们提出的算法有望帮助标准化未来研究中 STIC 的分类。